Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-14
1999-07-06
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514381, 544373, 548492, 548494, 548495, A61K 31405, A61K 31495, C07D40312, C07D20912
Patent
active
059198109
ABSTRACT:
A class of novel 1H-indole-3-glyoxylamides is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
REFERENCES:
patent: 2825734 (1958-03-01), Speeter
patent: 3242163 (1966-03-01), Sarett et al.
patent: 3259622 (1966-07-01), Shen et al.
patent: 3351630 (1967-11-01), Shen
patent: 3449363 (1969-06-01), Littel
patent: 3624103 (1971-11-01), DeMartilis et al.
patent: 3691194 (1972-09-01), Papanastassion
patent: 3801594 (1974-04-01), Poletto
patent: 4012513 (1977-03-01), Birchall et al.
patent: 4397850 (1983-08-01), Madelson
patent: 4552876 (1985-11-01), Jones et al.
patent: 5334719 (1994-08-01), Frenette
patent: 5420289 (1995-05-01), Musser et al.
patent: 5639780 (1997-06-01), Lau et al.
Julia, Marc; Igolen, Jean; and Igolen, Hanne; Recherches en serie indolique. VI Sur quelques tryptamines substitutees Bul. Soc. Chem., France, 1962, pp. 1060-1068.
Romeo, E., "2-Aryl-3-Indoleglyoxylamides (FGIN-1) : A New Class of Potent and Specific Ligands for the Mitochondrial DBI Receptor (MDR)", The Journal of Pharmacology and Experimental Therapeutics, vol. 262, No. 3, pp. 971-978 (1992).
Chemical Abstracts, vol. 67, 73028h, 1967, "Fragmentation of N-benzylindoles in Mass Spectrometry".
Alemany, A; Alvarez, E.; Lopez, O. And Herraez, M.E.; No. 565-"Inhibiteurs d'enzymes. XII-Preparation de (propargyamino-2-ethyl)-3 indoles"; Bulletin Do La Societe Chimique De France, 1974, No. 12, pp. 2883-2888.
Kollenz, Gert; Labes, Christa; "Indol-Umlagerung von 1-Diphenyl amino-2, 3-dihydro-2, 3-pyrrolidionen"; Liebigs Ann. Chem., 1975, pp. 1979-1983.
Kreft, A.; Nelson, J. Et al.; "Structure-activity relationships leading to WY-121,520 a tris aryl type, Nidomethacin-based, phospholipase A2 (PLA2) /leukotriene biosynthesis inhibitor", Issue vol. 39 (1993), pp. C33-C35, ISSN 0065-4299; publ. By Birkhauser Verlag, Basel Switzerland; (Proceeding of the Sixth International Research Assoc., Sep. 20-24, 1992 at White Haven, PA/USA, Ed., D.W. Morgan and A.K. Welton.
Seilhamer, Jeffery, et al., "Cloning and Recombinant Expression of Phospholipase A2 present in Rheumatoid Arthritic Synovial Fluid"; The Journal of Biological Chemistry, 254:10, Apr. 5, 1989, pp. 5335-5338.
Kramer, Ruther et al., "Structure and Properties of a Human Non-Pancreatic Phospholipase A2", The Journal of Biological Chemistry, 264:10, Apr. 5, 1989, pp. 5768-5775.
Reynolds, et al., "Analysis of Human Synovial Fluid Phospholipase A2 on Short Chain Phosphatidylcholine-Mixed Micelles: Development of a Spectrophotometric Assay Suitable for a Microtiterplate Reader", Analytical Biochem, 204, pp. 190-197, 1992.
Rossum, et al., "Cumulative Dose-Response Curves II. Technique for the making of dose response curves in isolated organs and the evaluation of drug parameters," Arch. Int. Pharmacodyn. 143, No. 34, pp. 299-330, 1963.
Wald, Douglas R., "Analysis of Dose-Response Relationships", Dept. Of Pharma., Univ. Of Mass. Med. Center, 145-179 (no date available).
Andreani, A., et al., "Nonsteroidal Antiinflammatory Agents. 2. Synthesis and Biological Activity of 2-Chlorindolecarboxylic Acids"; Journal of Medicinal Chemistry, vol. 20, No. 10, 1977, pp. 1344-1346.
Julia, Marc., et al., "No.208--Recherches en serie indolique. XIII. Sur quelques methoxy -5 et. -6 tryptamines", Bulletin de La Societe Chemique de France, Paris France; 1965, pp. 1411-1417.
Chemical Abstracts, vol. 1/2 No. 24, Abstract No. 223181s; "Kinetis of hydrolysis of indomethacin and indomethacin ester predrugs in aqueous solution" Jun. 11, 1990, p. 407.
Chemical Abstracts Service. "Registry Handbook", Number Section, Registry Numbers (see, CAS RN 6264-33-1) 1965-1971, Publ. American Chemical Society.
Von K.H. Boltze; O. Brendler, et al., "Chemische Struktur and antiphlogistische Wirkung in der Reihe der substituierten Indol-3-essigsauren," Arznermittel Forschung Drug Research, vol. 30 (II), No. 8A, 1980, Aluendorf, DE, pp. 1314-1325.
Dillard, Robert D., et al., Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2-1. Indole-3-acetamides, Journal of Medicinal Chemistry, vol. 39, No. 26, pp. 5119-5136.
Dillard, Robert D., et al., Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2-2. Indole-3-acetamides with Additional Functionality, Journal of Medicinal Chemistry, vol. 39, No. 26, pp. 5137-5158.
Draheim, Susan E., et al., Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2-3. Indole-3-glyoxamides, Journal of Medicinal Chemistry, vol. 39, No. 26, pp. 5159-5175.
Bach Nicholas J.
Dillard Robert D.
Draheim Susan E.
Benjamin Roger S.
Eli Lilly and Company
Oswecki Jane C.
Richter Johann
LandOfFree
1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-899357